Search
for
Sort by
Research 481–510 of 1000+
- Serum Level of Survivin in Patients with Alopecia Areata and its Association with Disease Severity and Progression
- Evaluation of CD4+, CD39+, FOXP3+Tregulatory cells in Iraqi Alopecia areata patients by ELISA
- Serum Level of Interleukin 17 in Alopecia Areata Patients and Its Relation with the Severity of the Disease: a Case Control Study
- Dietary Habits in Japanese Patients with Alopecia Areata
- Evaluation of Serum Level of Zinc and Biotin in Patients with Alopecia Areata
- Serum Interleukin 19 in Patients with Alopecia Areata
- Serum Levels of Transforming Growth Factor Beta1 (TGF β1) in Patients with Alopecia Areata.
- Evaluation of Serum levels of epidermal growth factor (EGF) in Patients with alopecia areata
- 526 Gut dysbiosis in alopecia areata patients reveals overabundance of firmicutes and under representation of bacteroides
- Red Blood Cells Folate Level in Patients with Alopecia Areata
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Increased risk of alopecia areata in patients with autism spectrum disorders: A Korean nationwide population-based study
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Treatment of Widespread Alopecia Areata in Young Patients with Monthly Oral Corticosteroid Pulse
- 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- Investigate the role of Zinc and Ferritin in Iraqi patients with alopecia areata
- Comparison of Various Treatment Modalities in patients with Alopecia Areata
- Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern
- Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita
- Alopecia areata: a long‐term follow‐up study of 104 patients
- Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata
- Response to ustekinumab in three pediatric patients with alopecia areata
- Changes of serum trace elements level in patients with alopecia areata: A meta‐analysis
- Alopecia areata predictive score: A new trichoscopy‐based tool to predict treatment outcome in patients with patchy alopecia areata
- Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata
- Beard alopecia areata: a multicentre review of 55 patients
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Identification of blood microRNA alterations in patients with severe active alopecia areata
- Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective
- Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata